---
category: news
title: "Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid"
excerpt: "Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the expansion of its artificial intelligence (AI) capability with the signing of an agreement to acquire Vienna-based Dedicaid GmbH (Dedicaid),"
publishedDateTime: 2023-04-27T00:45:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/telix-accelerates-artificial-intelligence-ai-development-program-with-acquisition-of-dedicaid-1032265571"
webUrl: "https://markets.businessinsider.com/news/stocks/telix-accelerates-artificial-intelligence-ai-development-program-with-acquisition-of-dedicaid-1032265571"
type: article

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - Machine Learning
  - AI

secured: "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;bei/nDVfW+zHSX8ux2OgSg=="
---

